Veloxis Stock Today

<div class='circular--portrait' style='background:#8B008B;color: #ffffff;font-size:4em;padding-top: 25px;;'>VP</div>
Equity ratings for Veloxis Pharmaceuticals AS are calculated daily based on the scoring framework. The performance scores are derived for the period starting the 25th of February 2020 and ending today, the 25th of May 2020. Click here to learn more.
Analyze Filter   Check how we calculate scores
Veloxis Pharmaceuticals AS cannot be verified against its exchange. It looks like Veloxis Pharmaceuticals is not available for investing at the moment. Please verify the symbol is currently traded on Copenhagen Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Veloxis Pharmaceuticals Profile

Veloxis Pharmaceuticals AS, a specialty pharmaceutical company, engages in enhancing the lives of transplant patients by identifying, developing, and commercializing products in transplantation. The company was formerly known as LifeCycle Pharma AS and changed its name to Veloxis Pharmaceuticals AS in July 2011. Veloxis Pharmaceuticals operates under Pharmaceuticals And Biosciences classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 58 people.. The public information regarding Veloxis Pharmaceuticals AS's current market price is not available at this time.
Legal NameVeloxis Pharmaceuticals AS
Thematic Classifications
Active investing themes Veloxis Pharmaceuticals currently participates. An investing theme is an unweighted collection of funds, stocks, ETFs or cryptocurrencies
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Veloxis Pharmaceuticals AS (VELO) is traded on Copenhagen Stock Exchange in Denmark and employs 58 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 5.64 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Veloxis Pharmaceuticals's market, we take the total number of it shares issued and multiply it by the Veloxis Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Veloxis Pharmaceuticals operates under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 1.73 B outstanding shares. VELOXIS PHARMACEU has accumulated about 28.39 M in cash with (8.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Check Veloxis Pharmaceuticals Probability Of Bankruptcy

Veloxis Stock Against Markets

Veloxis Pharmaceuticals AS cannot be verified against its exchange. It looks like Veloxis Pharmaceuticals is not available for investing at the moment. Please verify the symbol is currently traded on Copenhagen Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

Check out World Market Map. Please also try Theme Ratings module to determine theme ratings based on digital equity recommendations. macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page